These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11831450)

  • 1. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm.
    García R; Guerra P; Feo F; Galindo PA; Gómez E; Borja J; Fernandez-Pacheco R
    J Investig Allergol Clin Immunol; 2001; 11(3):176-82. PubMed ID: 11831450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formoterol provides long-lasting protection against exercise-induced bronchospasm.
    Bronsky EA; Yegen U; Yeh CM; Larsen LV; Della Cioppa G
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):407-12. PubMed ID: 12392386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma.
    Ferrari M; Balestreri F; Baratieri S; Biasin C; Oldani V; Lo Cascio V
    Respiration; 2000; 67(5):510-3. PubMed ID: 11070454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
    Shapiro GS; Yegen U; Xiang J; Kottakis J; Della Cioppa G
    Clin Ther; 2002 Dec; 24(12):2077-87. PubMed ID: 12581546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction.
    Lazarinis N; Jørgensen L; Ekström T; Bjermer L; Dahlén B; Pullerits T; Hedlin G; Carlsen KH; Larsson K
    Thorax; 2014 Feb; 69(2):130-6. PubMed ID: 24092567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children.
    Pearlman D; Milgrom H; Till D; Ziehmer B
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):382-8. PubMed ID: 17042146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P; Vliers S; De Saint-Moulin T; Godding V
    Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test.
    Ferrari M; Segattini C; Zanon R; Bertaiola M; Balestreri F; Brotto E; Lo Cascio V
    Respiration; 2002; 69(6):509-12. PubMed ID: 12457003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formoterol, a new long-acting bronchodilator for inhalation.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Wåhlander L; Svedmyr N
    Eur Respir J; 1989 Apr; 2(4):325-30. PubMed ID: 2737271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect and duration of action of formoterol aerosol on exercise-induced asthma.
    Patessio A; Podda A; Carone M; Trombetta N; Donner CF
    Eur Respir J; 1991 Mar; 4(3):296-300. PubMed ID: 1677894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S; Hancox RJ
    Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term salmeterol treatment on exercise-induced asthma.
    Nelson JA; Strauss L; Skowronski M; Ciufo R; Novak R; McFadden ER
    N Engl J Med; 1998 Jul; 339(3):141-6. PubMed ID: 9664089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection.
    Davis BE; Reid JK; Cockcroft DW
    Can Respir J; 2003; 10(1):23-6. PubMed ID: 12650133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.